Two novel radiolabeled small molecules targeting prostate-specific membrane antigen (PSMA) have excellent potential for further development as diagnostic and therapeutic radiopharmaceuticals, according to research published in The Journal of Nuclear Medicine. The imaging agents —123I-MIP-1072 and 123I-MIP-1095 — were shown to have a high sensitivity of lesion detection in bone, soft tissue and the prostate gland with minimal retention in non-target tissue.

Fovia Medical Inc. and Contrast Imaging have collaborated to make natively integrated high definition volume rendering (HDVR) available throughout Contrast Imaging’s entire digital offering. With Fovia’s flexible and scalable advanced visualization HDVR software, Contrast Imaging can further streamline its fast, stable and integrated workflows at imaging centers throughout Australia.

Forty-three of 44 providers interviewed by KLAS Research said they would buy tomosynthesis (3-D mammography) again despite the additional time it takes and the unpredictable reimbursement. This and other findings are available in the new KLAS report “Breast Tomosynthesis 2013: The Business Case.”

Representatives Dave Reichert (R-WA), Jim Matheson (D-UT), Pete Olson (R-TX) and Bill Pascrell (D-NJ) have introduced the Medicare Access to Radiology Care Act of 2013 (H.R. 1148).This bill would amend the Social Security Act to recognize radiologist assistants (RAs) as non-physician providers of healthcare services to Medicare beneficiaries, and it would authorize physician reimbursement through the Centers for Medicare & Medicaid Services (CMS) for procedures performed by RAs in states that have laws establishing radiologist assistant practice guidelines.

Royal Philips Electronics is introducing three new imaging systems to help radiology departments increase both the number of patients and range of clinical exams they can handle. Showcased at the 2013 European Congress of Radiology (ECR 2013), all three systems combine the capabilities for high patient throughput with the functionality and advanced clinical imaging applications.

Lantheus Medical Imaging Inc. announced a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLite (Technetium Tc 99m Generator) generators.